ZimVie Inc
NASDAQ:ZIMV
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
US |
Z
|
ZimVie Inc
NASDAQ:ZIMV
|
458.7m USD | 3.1 | |
US |
Abbott Laboratories
NYSE:ABT
|
181.5B USD | 8.4 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
139.8B USD | 27.7 | ||
US |
Stryker Corp
NYSE:SYK
|
125.1B USD | 10 | ||
IE |
Medtronic PLC
NYSE:MDT
|
111.8B USD | 6.1 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
109.5B USD | 11.4 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 10 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.4B EUR | 8.9 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
376.2B CNY | 15.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
53.7B USD | 11.2 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.3B USD | 21.2 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.